Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities
|2||Active, not recruiting||
Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome
Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma
Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
† Study has passed its completion date and status has not been verified in more than two years.